Front Range Biosciences Funding: $133M Raised, Series B
Front Range Biosciences is based in Boulder, Colorado. It has raised $133M in total funding. Latest round: Series B.
Front Range Biosciences funding overview
Front Range Biosciences is based in Boulder, Colorado. Front Range Biosciences has raised $133M in total disclosed funding. That places its disclosed total in the $100M–$250M range. Its most recent disclosed round is a Series B announced in August 2020. The round record for Front Range Biosciences runs through 2020; nothing later has been disclosed. Investors on record include Phyto Partners, Salveo Capital, Sand Hill Angels, HBS Angels of NYC, NY Angels, Halley Venture Partners and 6 others. 12 distinct backers are named across the disclosed rounds.
Front Range Biosciences at a glance
Total raised
$133M
Latest round
Series B
Latest round date
August 2020
Headquarters
Boulder, Colorado
Notable investors
Phyto Partners, Salveo Capital, Sand Hill Angels, HBS Angels of NYC, NY Angels, Halley Venture Partners, Anthill Ventures, Canopy Boulder
Frequently asked about Front Range Biosciences funding
How much has Front Range Biosciences raised?
Front Range Biosciences has raised $133M in total disclosed funding across the rounds on record.
Who has invested in Front Range Biosciences?
Phyto Partners, Salveo Capital, Sand Hill Angels, HBS Angels of NYC, NY Angels, Halley Venture Partners are named among the investors backing Front Range Biosciences.
What was the latest Front Range Biosciences funding round?
The most recent disclosed round is a Series B, announced in August 2020.
Where is Front Range Biosciences based?
Front Range Biosciences is based in Boulder, Colorado.
When did Front Range Biosciences last raise?
The last disclosed Front Range Biosciences round closed in August 2020 at Series B.
Front Range Biosciences totals reflect disclosed capital only — undisclosed extensions and secondaries are excluded. Use the related companies in Boulder below to benchmark round size and investor mix.
